Viol

What Viol does

VIOL Medical Co., Ltd. is a South Korea-based medical aesthetic device manufacturer founded in 2009 and headquartered in Seongnam (Bundang), with a secondary office in Pangyo. The company designs, manufactures, and globally distributes energy-based devices built on proprietary radio frequency (RF) and high-intensity focused ultrasound (HIFU) technology. Its core product platform spans RF microneedling systems (SYLFIRM X, SCARLET S, SCARLET PRO) with 0.3mm needles and dual-wave (continuous/pulsed) energy delivery, a monopolar RF device (CELLINEW) operating at 6.78MHz with real-time impedance measurement, and a HIFU system (DUOTITE) with 4/7MHz dual-frequency handpieces. Underlying technology is protected by the NA EFFECT RF delivery patent portfolio, granted across Russia, Japan, Mexico, China, Australia, and Singapore, and further supported by 10+ device and method patents and 31 peer-reviewed clinical publications in SCI(E)-indexed journals. A U.S. International Trade Commission patent victory in 2025 affirmed Sylfirm X as a patented original technology.

VIOL generates revenue primarily through B2B capital equipment sales to medical aesthetic clinics, dermatology practices, and aesthetic medicine professionals worldwide, supplemented by a recurring consumables stream from proprietary tip cartridges, return pads, coupling fluid, and cooling gas tied to the installed device base. The go-to-market model is a hybrid of direct enterprise sales, event-driven demand generation at international exhibitions (IMCAS, AAD, AMWC, COSMOPROF Asia), and a 60+ country distributor network with named partners including Haju Medical (Indonesia/India), Sahwan Pharmaceutical (China), and Aesthetic Management Partners (U.S.). The company holds regulatory clearances from FDA, CE-MDR, China NMPA, Brazil ANVISA, Taiwan TFDA, and Korea MFDS, enabling market access across the Americas, Europe, Middle East, Asia, Oceania, and Africa.

In 2025, VIOL was acquired by private equity firm VIG Partners for KRW 521.3 billion and delisted from KOSDAQ via a stock exchange completed in March 2026 at KRW 12,500 per share. The company subsequently entered a strategic partnership and equity investment with Amorepacific (signed March 2026) to converge professional energy-based devices with consumer skincare, and operates today as a privately held, PE-backed global medical aesthetics platform with five core product lines, an accelerating international distributor footprint, and an active cadence of new product launches and geographic regulatory approvals.

Name

Viol

Legal name

VIOL Medical Co., Ltd.

Website

https://viol.co.kr

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

11–50 employees

Short description

VIOL Medical is a South Korea-based, PE-owned manufacturer of RF microneedling, monopolar RF, and HIFU medical aesthetic devices (Sylfirm X, Scarlet S, Scarlet Pro, Cellinew, Duotite), sold via a 60+ country distributor network to clinics and dermatologists globally, with FDA, CE-MDR, NMPA, ANVISA, and TFDA regulatory clearances.

Ownership category

akta.pro rank

Product category

Medical Aesthetic Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK)

akta.pro secondary industry

Detox, Lymphatic & Body Contouring Treatments (Non-Medical) (HSALAFAJ)

Keywords

• Medical aesthetic devices
• RF microneedling systems
• HIFU lifting devices
• Monopolar RF equipment
• Energy-based aesthetics

Headquarters

HQ city

Seongnam

HQ country

South Korea

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Operations, Marketing or Sales, Personnel, Supply Chain

Revenue model

1. Medical Aesthetic Device Sales: VIOL Medical generates revenue primarily through the sale of proprietary medical aesthetic hardware devices including RF microneedling systems (SYLFIRM X, SCARLET S), monopolar RF devices (CELLINEW), and HIFU systems (DUOTITE). These are capital equipment purchases made by clinics, dermatologists, and medical aesthetic practitioners worldwide.
2. Consumables and Accessories: Revenue is generated from consumable products required for device operation including needle tips (X Tip, XE Tip, XA Tip, XW Tip, XB Tip for SYLFIRM X; F/B/L tips for SCARLET S), return pads, coupling fluid, and gas cans (HFC134a for CELLINEW). These create recurring revenue from the installed device base.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels8 records

Core offering

VIOL Medical manufactures and sells proprietary medical aesthetic devices based on radiofrequency (RF) and high-intensity focused ultrasound (HIFU) technologies. The product portfolio includes RF microneedling systems (SYLFIRM X, SCARLET S, SCARLET PRO), a monopolar RF lifting device (CELLINEW), and a HIFU device (DUOTITE). These are capital equipment products sold B2B to dermatology clinics, medical aesthetic practices, and licensed practitioners worldwide, with recurring consumables revenue from disposable tips, return pads, and coupling fluids.

Product overview

VIOL Medical is a global medical aesthetic device company specializing in RF (radiofrequency) technology-based devices. The product portfolio centers on four core RF technology platforms: RF microneedling (SYLFIRM X, SCARLET S, SCARLET PRO), Monopolar RF (CELLINEW), and HIFU/High-Intensity Focused Ultrasound (DUOTITE). These devices are designed for skin rejuvenation, lifting, scar treatment, melasma management, and anti-aging procedures. The company operates from South Korea and exports to over 60 countries worldwide, with global certifications including FDA, CE, and various regional regulatory approvals.

Differentiator

Problem solved

Functional benefit

Products and services

• DUOTITE HIFU (High-Intensity Focused Ultrasound) device featuring DUO CARE for multi-layer targeting and DOT CARE for precise lifting. Dual-type lifting system with Basic and Pen handpieces operating at 4MHz and 7MHz frequencies for facial and body treatments.
• CELLINEW Monopolar RF device operating at 6.78MHz that delivers thermal energy uniformly and precisely to the skin. Features auto-impedance measurement and real-time output control with contact and gas cooling systems for safe non-invasive lifting and tightening treatments.
• SYLFIRM X RF microneedling device with 0.3mm micro-needles and dual wave mode (CW continuous wave and PW pulsed wave). Features 8 treatment modes with various tip configurations (X Tip, XE Tip, XA Tip, XW Tip, XB Tip, XB-49 Pin Tip) for treating melasma, wrinkles, acne, and acne scars.
• SCARLET S RF microneedling device with precise depth control (0.5-3.5mm in 0.1mm increments) for accurate thermal energy delivery and stable fractional RF energy at 2MHz. Features F (Face), B (Body), and L (Long) electrode types.
• SCARLET PRO Advanced RF microneedling device with enhanced safety and precision technologies to improve clinical outcomes and practice growth. Launched in U.S. market through partnership with Aesthetic Management Partners (AMP).

Quantifiable outcome

• RF Microneedling Device market projected to grow from $481M (2024) to $890M by 2031 at 9.3% CAGR
• +1 more outcomes

Named customers6 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Five partnerships are on record, tiered core and major.

• Sahwan Pharmaceutical (사환제약)coreChannel Partner/ Reseller/ Distributor · 12 June 2026VIOL Medical entered into an additional supply agreement with Sahwan Pharmaceutical for SYLFIRM X in China, expanding their existing partnership. Sahwan Pharmaceutical is a pharmaceutical/cosmetics company based in China.
• Haju Medical (인도네시아)coreChannel Partner/ Reseller/ Distributor · 12 June 2026VIOL Medical partnered with Haju Medical for Sylfirm X distribution and training in the Indonesia/India markets. Haju Medical hosted Sylfirm X training sessions as a regional partner.
• AmorepacificmajorStrategic or Co-development Partner · 27 March 2026Amorepacific signed an MOU with VIOL Medical on March 27, 2026, to collaborate in beauty and medical device sectors. The partnership involves joint product development, marketing, and a strategic investment by Amorepacific in VIOL Medical. The collaboration aims to integrate skincare with energy-based medical devices, connecting professional treatments with home beauty solutions and expanding into global markets.
• Aesthetic Management Partners (AMP)coreChannel Partner/ Reseller/ Distributor · 21 October 2025Aesthetic Management Partners (AMP) announced a strategic partnership with VIOL Medical for the U.S. launch of Scarlet Pro, an advanced RF microneedling device. The partnership aims to deliver innovation in aesthetic technology with enhanced safety and precision technologies to improve clinical outcomes and practice growth.
• Hubei Liftera / Sichuan Group (China)coreChannel Partner/ Reseller/ Distributor · 1 January 2022VIOL Medical signed SCARLET S supply agreements with Hubei Liftera and Sichuan Group for the China market in 2022.

Scale indicators6 records

Recent moves8 records

Expansion highlights6 records

Emerging players

• EndyMed Medical: Israeli company specializing in 3DEEP RF technology for aesthetic applications including Intensif RF microneedling. Niche overlap with Viol's Sylfirm X in RF microneedling segment.

Direct peers

• Cutera: Cutera's Secret RF and Morpheus8-style systems compete in RF microneedling, while truSculpt offers monopolar RF body contouring similar to CELLINEW. Directly comparable in target market (aesthetic clinics) and technology platform.
• InMode: InMode offers Morpheus8 (RF microneedling), BodyTite/FaceTite (RF), and Evoke/Evolv (HIFU/EMFACE) energy-based aesthetic devices. Direct competitor across multiple Viol platforms with strong US market presence.
• Lutronic: Korean-headquartered aesthetic device maker with INFINI RF microneedling, Clarity II (laser), and other energy-based systems. Closest Korean peer in scale, regulatory strategy, and product mix versus Viol.
• Cynosure: Cynosure's Potenza device is a major RF microneedling platform competing with Sylfirm X and Scarlet. Also offers TempSure (monopolar RF) and other energy-based systems overlapping Viol's CELLINEW product.
• Solta Medical (a division of AbbVie): Solta's flagship product Morpheus8 is the dominant RF microneedling device globally. Directly comparable to Viol's Sylfirm X and Scarlet platforms in technology, clinical applications, and customer base (dermatologists and plastic surgeons).
• Classys: Korean competitor with Ultraformer HIFU platform directly competing with Viol's DUOTITE HIFU device. Similar geographic strategy focused on Asian aesthetic markets and global export expansion.
• BTL Industries: BTL's Exilis (monopolar RF), EmFace (RF + HIFU facial lifting), and EMSCULPT compete directly with Viol's CELLINEW monopolar RF and DUOTITE HIFU platforms in body contouring and facial lifting aesthetics.
• Jeisys Medical: Korean aesthetic device company offering INTRAcel RF microneedling, Ultravera HIFU, and other energy-based platforms. Direct peer in target customer (Korean aesthetic clinics), regulatory approach, and product portfolio.

Broad incumbents

• Sisram Medical: Alma Lasers parent company offering multiple energy-based aesthetic platforms including RF, HIFU, and laser systems. Broader incumbent competitor with established global distribution competing across Viol's entire portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCOsEOMu_RhXHHwsS34qFdvQ
• LinkedInlinkedin.com/company/viol-co-ltd
• Instagraminstagram.com/viol.medical
• Facebookfacebook.com/violkorea

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Viol